Both Cdk5 and RPM-1 are involved in axon degeneration [11,55,70–72], and genetically interact with players involved in Alzheimer’s disease, such as Tau and tubulin acetyltransferase [42,49,73]. Here, MAPT is linked to early-onset autosomal dominant Alzheimer disease.